Article
Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan.
Malaria journal - 23 Jun 2011
Howard Natasha, Durrani Naeem, Sanda Sanda, Beshir Khalid, Hallett Rachel, Rowland Mark
Abstract excerpt
BACKGROUND: Falciparum malaria is a significant problem for Afghan refugees in Pakistan. Refugee treatment guidelines recommended standard three-day chloroquine treatment (25 mg/kg) for first episodes and extended five-day treatment (40 mg/kg) for recrudescent infections, based on the assumption that a five-day course would more likely achieve a cure. An in-vivo randomized controlled trial was conducted among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
